Alcon
Alcon Inc. is a Swiss-American eye care medical device company that specializes in surgical equipment and vision care products. The company operates through two primary operational business segments, Surgical and Vision Care, catering to ophthalmic professionals and consumers worldwide. Its product offerings include intraocular lenses, cataract and vitreoretinal surgical equipment, contact lenses, and over-the-counter dry eye drops such as Systane. Revenue is predominantly generated from the sale of surgical consumables, ophthalmic medical equipment, contact lens products, and eye hygiene solutions. Principal end markets comprise eye surgery centers, ophthalmic surgeons, optometrists, retail optical chains, and individual consumers across global markets. Positioned as the world's largest eye care device manufacturer, the company holds the leading market share in cataract and refractive surgery equipment. Headquartered in Geneva, Switzerland, Alcon Inc. is dual-listed on the SIX Swiss Exchange and the New York Stock Exchange under ticker symbol ALC.
56 of the funds FundTelligence covers report a position in Alcon.
- Legal name
- Alcon Inc
- Sector
- Health Care
- Country
- Switzerland
- Funds holding it
- 56
- Exposure themes
- Ageing & Longevity, Healthy Ageing & Function, Vision
Funds holding Alcon
- Schroder ISF European Equity Impact — Schroders · 4.35 % (full portfolio disclosed, December 2025)
- BNP Europe Growth Capitalisation — BNP Paribas · 3.33 % (largest positions only, October 2026)
- UBS Sustainable Health Transformation Equity Fund — UBS · 3.3 % (largest positions only, September 2026)
- BlackRock iShares MSCI Europe Health Care Sector UCITS ETF — BlackRock · 1.84 % (full portfolio disclosed, October 2026)
- BNP Europe Equity — BNP Paribas · 1.82 % (full portfolio disclosed, December 2025)
- Templeton European Insights Fund — Franklin Templeton · 1.78 % (full portfolio disclosed, September 2026)
- Schroder ISF US Large Cap — Schroders · 1.2 % (full portfolio disclosed, June 2026)
- BNP Health Care Innovators — BNP Paribas · 1.16 % (full portfolio disclosed, June 2026)
Showing the 8 largest of 56 funds holding it.